Cargando…
Neuroendocrine carcinoma of gallbladder: a case series and literature review
BACKGROUND: Neuroendocrine carcinoma (NEC) of gallbladder is a rare tumor. The clinical manifestation, treatment, and prognosis of gallbladder NEC are rarely reported. CASE PRESENTATION: Eight gallbladder NEC patients were admitted into our hospital. The major complaint was right upper quadrant pain...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362567/ https://www.ncbi.nlm.nih.gov/pubmed/30717775 http://dx.doi.org/10.1186/s40001-019-0363-z |
_version_ | 1783392945205936128 |
---|---|
author | Liu, Wei Chen, Weijie Chen, Jiemin Hong, Tao Li, Binglu Qu, Qiang He, Xiaodong |
author_facet | Liu, Wei Chen, Weijie Chen, Jiemin Hong, Tao Li, Binglu Qu, Qiang He, Xiaodong |
author_sort | Liu, Wei |
collection | PubMed |
description | BACKGROUND: Neuroendocrine carcinoma (NEC) of gallbladder is a rare tumor. The clinical manifestation, treatment, and prognosis of gallbladder NEC are rarely reported. CASE PRESENTATION: Eight gallbladder NEC patients were admitted into our hospital. The major complaint was right upper quadrant pain. Two patients underwent a radical resection of gallbladder and liver quadrate lobe. One of them underwent chemotherapies and had no recurrence of NEC during a 25-month followed-up period. The other patient did not undergo chemotherapies, and the NEC recurred in the patient 15 months afterwards. Two patients underwent a radical resection of gallbladder. One of them underwent chemotherapies and had an NEC recurrence 12 months afterwards. The other patient did not undergo chemotherapies and died due to the NEC recurrence 5 months after surgery. Three patients underwent a laparoscopic cholecystectomy and pathologic result showed gallbladder NEC. They did not undergo further treatment and no NEC recurrence was found. One patient underwent tumor biopsy and died due to obstructive jaundice 3 months afterwards. Pathologic results showed that all cases had positive chromogranin A and synaptophysin staining. CONCLUSIONS: Gallbladder NEC showed no noticeably specific features, and the diagnosis relied on the pathological and immunohistochemistrical results. For T1N0M0 gallbladder NEC, cholecystectomy might be enough. For patients in a late stage, the management of combined therapies might be optimal. |
format | Online Article Text |
id | pubmed-6362567 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-63625672019-02-14 Neuroendocrine carcinoma of gallbladder: a case series and literature review Liu, Wei Chen, Weijie Chen, Jiemin Hong, Tao Li, Binglu Qu, Qiang He, Xiaodong Eur J Med Res Case Report BACKGROUND: Neuroendocrine carcinoma (NEC) of gallbladder is a rare tumor. The clinical manifestation, treatment, and prognosis of gallbladder NEC are rarely reported. CASE PRESENTATION: Eight gallbladder NEC patients were admitted into our hospital. The major complaint was right upper quadrant pain. Two patients underwent a radical resection of gallbladder and liver quadrate lobe. One of them underwent chemotherapies and had no recurrence of NEC during a 25-month followed-up period. The other patient did not undergo chemotherapies, and the NEC recurred in the patient 15 months afterwards. Two patients underwent a radical resection of gallbladder. One of them underwent chemotherapies and had an NEC recurrence 12 months afterwards. The other patient did not undergo chemotherapies and died due to the NEC recurrence 5 months after surgery. Three patients underwent a laparoscopic cholecystectomy and pathologic result showed gallbladder NEC. They did not undergo further treatment and no NEC recurrence was found. One patient underwent tumor biopsy and died due to obstructive jaundice 3 months afterwards. Pathologic results showed that all cases had positive chromogranin A and synaptophysin staining. CONCLUSIONS: Gallbladder NEC showed no noticeably specific features, and the diagnosis relied on the pathological and immunohistochemistrical results. For T1N0M0 gallbladder NEC, cholecystectomy might be enough. For patients in a late stage, the management of combined therapies might be optimal. BioMed Central 2019-02-04 /pmc/articles/PMC6362567/ /pubmed/30717775 http://dx.doi.org/10.1186/s40001-019-0363-z Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report Liu, Wei Chen, Weijie Chen, Jiemin Hong, Tao Li, Binglu Qu, Qiang He, Xiaodong Neuroendocrine carcinoma of gallbladder: a case series and literature review |
title | Neuroendocrine carcinoma of gallbladder: a case series and literature review |
title_full | Neuroendocrine carcinoma of gallbladder: a case series and literature review |
title_fullStr | Neuroendocrine carcinoma of gallbladder: a case series and literature review |
title_full_unstemmed | Neuroendocrine carcinoma of gallbladder: a case series and literature review |
title_short | Neuroendocrine carcinoma of gallbladder: a case series and literature review |
title_sort | neuroendocrine carcinoma of gallbladder: a case series and literature review |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362567/ https://www.ncbi.nlm.nih.gov/pubmed/30717775 http://dx.doi.org/10.1186/s40001-019-0363-z |
work_keys_str_mv | AT liuwei neuroendocrinecarcinomaofgallbladderacaseseriesandliteraturereview AT chenweijie neuroendocrinecarcinomaofgallbladderacaseseriesandliteraturereview AT chenjiemin neuroendocrinecarcinomaofgallbladderacaseseriesandliteraturereview AT hongtao neuroendocrinecarcinomaofgallbladderacaseseriesandliteraturereview AT libinglu neuroendocrinecarcinomaofgallbladderacaseseriesandliteraturereview AT quqiang neuroendocrinecarcinomaofgallbladderacaseseriesandliteraturereview AT hexiaodong neuroendocrinecarcinomaofgallbladderacaseseriesandliteraturereview |